Seattle Children's Hospital
4800 Sand Point Way NE, Po Box C-5371, Seattle, WA, 98105 ยท (206) 987-2000
$2.44B
Net patient revenue, FY 2025
$2.44B
Net patient revenue, FY 2025
Beds
381
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$2.44B
FY 2025
Net income
$437.0M
Patient care margin 17.2%
Discharges
12,445
Occupancy 78.1%
Clinicians
84
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
1 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.44B | $2.02B | 17.2% | $437.0M | 12,445 | $202 | 0.4% | 35.0% |
| 2024 | $2.11B | $1.87B | 11.3% | $289.8M | 10,290 | -$2K | 0.5% | 35.8% |
| 2023 | $1.91B | $1.80B | 5.7% | $106.3M | 9,417 | -$2K | 0.5% | 34.8% |
| 2022 | $1.70B | $1.61B | 5.7% | -$147.7M | 8,711 | -$6K | 0.6% | 28.2% |
| 2021 | $1.51B | $1.42B | 6.3% | $172.9M | 8,396 | -$5K | 0.8% | 24.0% |
| 2020 | $1.32B | $1.32B | -0.1% | $36.4M | 8,883 | -$7K | 0.8% | 25.8% |
Hospital profile
- Medicare certification number (CCN)
- 503300
- Organization NPI
- 1467536276
- Legal name
- Seattle Childrens Hospital
- County
- King County, WA
- Ownership
- Nonprofit (private)
- Teaching
- Major teaching
- In Medicare since
- 1983
- Full-time employees
- 7,138
- Health system
- Seattle Childrens Hospital Research and Foundation
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other hospitals in Seattle
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | - | - | - | $2,141.49 |
| APC 5154 Level 4 Airway Endoscopy | - | - | - | $2,832.62 |
| APC 5165 Level 5 ENT Procedures | - | - | - | $4,436.36 |
| APC 5192 Level 2 Endovascular Procedures | - | - | - | $4,338.16 |
| APC 5213 Level 3 Electrophysiologic Procedures | - | - | - | $21,117.37 |
| APC 5361 Level 1 Laparoscopy and Related Services | - | - | - | $4,357.80 |
| APC 5372 Level 2 Urology and Related Services | - | - | - | $502.15 |
| APC 5373 Level 3 Urology and Related Services | - | - | - | $1,516.28 |
| APC 8011 Comprehensive Observation Services | - | - | - | $2,090.36 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 6 | $14.3M |
| E.R. Squibb & Sons, L.L.C. | 2 | $5.8M |
| Pfizer Inc. | 57 | $1.2M |
| Regeneron Pharmaceuticals, Inc. | 52 | $395K |
| Eli Lilly and Company | 10 | $281K |
| Sarepta Therapeutics, Inc. | 23 | $274K |
| Merck Sharp & Dohme LLC | 10 | $273K |
| Rhythm Pharmaceuticals, Inc. | 112 | $225K |
| Sanofi US Services Inc. | 12 | $213K |
| Day One Biopharmaceuticals | 52 | $152K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.